Market Cap
$4.8B
+2.4% today
Sector & Industry
Healthcare
Pharmaceuticals
SEC Filings
702
Total filings on record
Last Filing
Jan 28, 2026
8-K — Board of Directors Update
Showing 15 filings
| Form Type | Filed Date | Accepted | Description | Accession | Actions |
|---|---|---|---|---|---|
| Form 4 | Jan 28, 2026 | Jan 28, 2026 | Statement of Changes - Michael Jones | 0006058813-26-963092 | |
| 10-K | Dec 22, 2025 | Dec 22, 2025 | Annual Report for fiscal year ended January 2025 | 0006058813-26-580151 | |
| 8-K | Nov 25, 2025 | Nov 25, 2025 | Current Report - Material Event Disclosure | 0006058813-26-538995 | |
| S-1 | Nov 1, 2025 | Nov 1, 2025 | Registration Statement | 0006058813-26-683714 | |
| 13F | Oct 3, 2025 | Oct 3, 2025 | Institutional Investment Manager Holdings Report | 0006058813-26-783627 | |
| 10-Q | Sep 11, 2025 | Sep 11, 2025 | Quarterly Report for period ended January 2025 | 0006058813-26-647776 | |
| 13F | Aug 7, 2025 | Aug 7, 2025 | Institutional Investment Manager Holdings Report | 0006058813-26-168204 | |
| 13F | Jul 11, 2025 | Jul 11, 2025 | Institutional Investment Manager Holdings Report | 0006058813-26-263225 | |
| Form 4 | Jun 14, 2025 | Jun 14, 2025 | Statement of Changes - James Jones | 0006058813-26-372295 | |
| 13F | May 24, 2025 | May 24, 2025 | Institutional Investment Manager Holdings Report | 0006058813-26-566694 | |
| S-1 | Apr 26, 2025 | Apr 26, 2025 | Registration Statement | 0006058813-25-833974 | |
| S-1 | Mar 19, 2025 | Mar 19, 2025 | Registration Statement | 0006058813-25-108100 | |
| S-1 | Feb 18, 2025 | Feb 18, 2025 | Registration Statement | 0006058813-25-343315 | |
| 10-Q | Feb 2, 2025 | Feb 2, 2025 | Quarterly Report for period ended June 2025 | 0006058813-25-150986 | |
| Form 4 | Dec 25, 2024 | Dec 25, 2024 | Statement of Changes - Sarah Williams | 0006058813-25-588743 |